GelStat Migraine proves effective against pain in first clinical trial
8th Sep 2005, 10:45 GMT
Pain specialist company GelStat has received promising results from the first clinical trial of GelStat Migraine, showing the treatment to be effective in 83% of migraine cases tested.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol